November 2008
1573
73.8 mmol), K3PO4 (83.2 mg, 0.385 mmol) and Ag3PO4 (39.1 mg, 91.5 mmol)
in xylene (1.0 ml) was stirred for 30 min at 40 °C. To this suspension, a solu-
tion of chloroformamide (E)-2 (100 mg, 0.186 mmol) in xylene (3.0 ml) was
added. After stirring for 5 h at 130 °C, the reaction mixture was cooled to
room temperature, and water was added, and the product was extracted with
EtOAc. The combined organic extracts were washed with water and brine,
dried over Na2SO4, and concentrated in vacuo. Purification by silica gel col-
umn chromatography (hexane/CHCl3/Et2Oꢂ1/0/0→60/16/24) afforded a
mixture containing enol ether, which was added acetone (3.0 ml), water
(0.1 ml) and p-TsOH·H2O (36.5 mg, 0.192 mmol). After stirring for 100 min
at 30 °C, aqueous NaHCO3 was added, and the product was extracted with
EtOAc. The combined organic extracts were washed with saturated aqueous
NaHCO3 and brine, dried over Na2SO4, and concentrated in vacuo. Purifica-
tion by silica gel column chromatography (hexane/EtOAcꢂ1/0→6/4) af-
forded piperidone 1 (39.8 mg, 52%) as a light yellow oil. Enantiomeric ex-
cess (ee) was measured by HPLC analysis with chiralcel AS-H column
(hexane/2-propanolꢂ95/5, 0.5 ml/min, 254 nm) tR: 36.9 min (S, minor),
83.5, 72.1, 66.4, 49.9, 49.3, 34.3, 28.5, 28.4, 25.9, 23.7, 13.5. IR (NaCl)
cmꢁ1: 2932, 1730, 1453, 1374, 1254, 1159, 1088. LR-MS (FAB) m/zꢂ477
(MꢀHꢀ). Anal. Calcd for C30H40N2O3: C, 75.59; H, 8.46; N, 5.88. Found: C,
75.41; H, 8.65; N, 5.89.
Amine (Z)-17 A solution of benzyl ether (Z)-4 (425 mg, 1.53 mmol) and
p-TsOH·H2O (576 mg, 3.03 mmol) in acetone (10 ml) and water (0.5 ml)
was stirred for 3 h at 40 °C. After adding aqueous NaHCO3, the mixture was
extracted with EtOAc. The combined extracts were washed with saturated
aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated in vacuo.
To a solution of this residue in THF (5.1 ml), were added tryptamine 3
(615 mg, 2.37 mmol) and MS4A (2.12 g). After stirring for 2 h at 40 °C,
MS4A was removed by filtration. To the filtrate, was added a solution of
NaBH4 (98% purity, 88.6 mg, 2.28 mmol) in MeOH (8.0 ml) at 0 °C. After
stirring for 1 h at room temperature, water was added, and the mixture was
extracted with EtOAc. The combined extracts were washed with water,
brine, dried over Na2SO4, and concentrated in vacuo. Purification by alu-
mina column chromatography (hexane/CHCl3ꢂ5/5→CHCl3/MeOHꢂ9/1)
afforded amine (Z)-17 (451 g, 62%) as a colorless oil. Rf 0.45 (alumina,
CH3Cl/MeOHꢂ9/1). 1H-NMR (CDCl3, 400 MHz) d: 8.13 (1H, br d,
Jꢂ7.8 Hz), 7.54 (1H, d, Jꢂ7.8 Hz), 7.41 (1H, br s), 7.35—7.22 (7H, m),
5.38 (1H, t, Jꢂ6.7 Hz), 4.48 (2H, s), 4.01 (2H, d, Jꢂ6.7 Hz), 2.95—2.86
(4H, m), 2.58 (2H, t, Jꢂ7.2 Hz), 2.07—2.01 (4H, m), 1.66 (9H, s), 1.58—
1.49 (2H, m), 1.01 (3H, t, Jꢂ7.5 Hz). 13C-NMR (CDCl3, 125 MHz) d:
149.8, 145.7, 138.6, 135.6, 130.7, 128.4, 127.9, 127.6, 124.4, 123.0, 122.4,
120.1, 119.0, 118.8, 115.4, 83.4, 72.2, 66.4, 49.8, 49.3, 29.4, 29.0, 28.5,
28.3, 25.8, 12.5. IR (NaCl) cmꢁ1: 2932, 1731, 1453, 1373, 1254, 1159,
1088. LR-MS (FAB) m/zꢂ477 (MꢀHꢀ). Anal. Calcd for C30H40N2O3: C,
75.59; H, 8.46; N, 5.88. Found: C, 75.85; H, 8.55; N, 5.83.
1
44.9 min (R, major) (43% ee). Rf 0.30 (silica gel, hexane/EtOAcꢂ6/4). H-
NMR (CDCl3, 400 MHz) d: 9.79 (1H, dd, J1ꢂ1.2 Hz, J2ꢂ2.4 Hz), 8.13 (1H,
br d, Jꢂ7.8 Hz), 7.62 (1H, d, Jꢂ7.8 Hz), 7.43 (1H, br s), 7.31 (1H, dd,
J1ꢂJ2ꢂ7.8 Hz), 7.24 (1H, dd, J1ꢂJ2ꢂ7.8 Hz), 3.69—3.57 (2H, m), 3.40—
3.34 (1H, m), 3.25—3.20 (1H, m), 2.96 (2H, t, Jꢂ7.6 Hz), 2.86 (1H, dd,
J1ꢂ1.2 Hz, J2ꢂ16.4 Hz), 2.43 (1H, dd, J1ꢂ2.4 Hz, J2ꢂ16.4 Hz), 1.85—1.68
(6H, m), 1.66 (9H, s), 0.90 (3H, t, Jꢂ7.5 Hz). 13C-NMR (CDCl3, 100 MHz)
d: 201.7, 173.8, 149.9, 135.7, 130.7, 124.5, 123.3, 122.7, 119.2, 118.0,
115.4, 83.5, 51.5, 49.0, 48.3, 43.7, 31.0, 30.1, 28.3, 22.8, 19.6, 8.3. IR
(NaCl) cmꢁ1: 2937, 1727, 1629, 1454, 1377, 1255, 1158. LR-MS (FAB)
m/zꢂ413 (MꢀHꢀ). [a]D ꢁ0.9 (cꢂ1.0, CHCl3). Anal. Calcd for
C24H32N2O4: C, 69.88; H, 7.82; N, 6.79. Found: C, 69.58; H, 8.00; N, 6.56.
Methyl Ester 18 A mixture of piperidone 1 (149 mg, 0.361 mmol),
2-methyl-2-butene (1.0 ml), NaClO2 (80% purity, 143 mg, 1.27 mmol),
NaH2PO4·2H2O (141 mg, 0.904 mmol) in t-BuOH (3.0 ml) and water
(1.5 ml) was stirred for 2 h. After adding saturated aqueous NH4Cl, the mix-
ture was extracted with CHCl3. The combined extracts were washed with
water and brine, dried over Na2SO4, and concentrated in vacuo. This residue
was dissolved in CH3CN (3.0 ml), and Cs2CO3 (142 mg, 0.436 mmol) and
MeI (0.025 ml, 0.40 mmol) were added at 0 °C. After stirring for 2.5 h, water
was added, and. the mixture was extracted with CHCl3. The combined
extracts were washed with water and brine, dried over Na2SO4, and con-
centrated in vacuo. Purification by silica gel column chromatography
(hexane/EtOAcꢂ1/0→6/4) afforded methyl ester 18 (144 mg, 90%) as a col-
orless oil. Rf 0.41 (silica gel, hexane/EtOAcꢂ6/4). 1H-NMR (CDCl3,
400 MHz) d: 8.13 (1H, br d, Jꢂ7.5 Hz), 7.65 (1H, d, Jꢂ7.5 Hz), 7.44 (1H,
br s), 7.31 (1H, dd, J1ꢂJ2ꢂ7.5 Hz), 7.24 (1H, dd, J1ꢂJ2ꢂ7.5 Hz), 3.71—
3.57 (5H, m), 3.46—3.40 (1H, m), 3.22—3.18 (1H, m), 3.02—2.91 (3H, m),
2.43 (1H, d, Jꢂ16.1 Hz), 1.98—1.55 (15H, m), 0.89 (3H, t, Jꢂ7.6 Hz). 13C-
NMR (CDCl3, 125 MHz) d: 174.1, 172.6, 149.9, 135.7, 130.7, 124.5, 123.3,
122.6, 119.3, 118.3, 115.3, 83.4, 51.5, 49.1, 48.5, 43.5, 42.2, 31.6, 29.4,
28.4, 22.8, 20.0, 8.7. IR (NaCl) cmꢁ1: 2942, 1733, 1635, 1454, 1377, 1255,
1160. LR-MS (FAB) m/zꢂ443 (MꢀHꢀ). [a]D ꢁ0.4 (cꢂ0.99, CHCl3). Anal.
Calcd for C25H34N2O5: C, 67.85; H, 7.74; N, 6.33. Found: C, 67.42; H, 7.78;
N, 6.24.
Chloroformamide (E)-2 To
a solution of triphosgene (349 mg,
1.18 mmol) in THF (10 ml) was added triethylamine (0.59 ml, 4.22 mmol)
followed by amine (E)-17 (1.42 g, 2.98 mmol) in THF (10 ml) at ꢁ78 °C.
The reaction mixture was warmed to room temperature, stirred for 1.5 h at
70 °C, and aqueous 1 M HCl was added at 0 °C. The mixture was extracted
with EtOAc, and the combined organic extracts were washed with 1 M HCl,
saturated aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated
in vacuo. Purification by silica gel column chromatography (hexane/
EtOAcꢂ1/0→9/1) afforded chloroformamide (E)-2 (1.29 g, 80%) as a color-
less oil. Rf 0.45 (silica gel, hexane/EtOAcꢂ8/2). 1H-NMR* (CDCl3,
400 MHz) d: 8.14 (1H, br d, Jꢂ7.3 Hz), 7.56 (1H, dd, J1ꢂ7.8 Hz,
J2ꢂ10.5 Hz), 7.42 (1H, br s), 7.34—7.22 (7H, m), 5.35 (1H, t, Jꢂ6.8 Hz),
4.50 (2H, s), 4.02 (2H, d, Jꢂ6.8 Hz), 3.72—3.61 (2H, m), 3.38—3.32 (2H,
m), 3.06—3.00 (2H, m), 2.06—2.00 (4H, m), 1.78—1.70 (2H, m), 1.67 (9H,
s), 0.95 (3H, t, Jꢂ7.6 Hz). 13C-NMR* (CDCl3, 125 MHz) d: 149.8, 149.3,
149.1, 144.7, 144.4, 138.6, 138.6, 135.7, 130.3, 130.2, 128.5, 127.9, 127.7,
124.83, 124.76, 123.5, 122.8, 121.6, 121.4, 118.9, 118.7, 116.9, 116.6,
115.6, 115.5, 83.9, 83.8, 72.43, 72.36, 66.3, 51.9, 51.4, 50.4, 50.3, 33.4,
33.3, 28.4, 26.7, 25.8, 24.7, 23.7, 23.4, 13.5. IR (NaCl) cmꢁ1: 2971, 1733,
1454, 1375, 1255, 1157, 1088. LR-MS (FAB) m/zꢂ538 (Mꢀ). Anal. Calcd
for C31H39ClN2O4: C, 69.06; H, 7.29; N, 5.20. Found: C, 69.08; H, 7.09; N,
5.18 (* ca. 1 : 1 mixture of rotamers).
Chloroformamide (Z)-2 To
a solution of triphosgene (69.8 mg,
0.235 mmol) in THF (1.0 ml) was added a solution of triethylamine (0.11 ml,
0.786 mmol) and amine (Z)-17 (273 mg, 0.573 mmol) in THF (4.0 ml) at
ꢁ78 °C. The reaction mixture was warmed up to 70 °C, and stirred for 2 h.
After successive addition of water and 1 M HCl at 0 °C, the mixture was ex-
tracted with EtOAc. The combined organic extracts were washed with 1 M
HCl, saturated aqueous NaHCO3 and brine. The organic layer was dried over
Na2SO4, and concentrated in vacuo. Purification by silica gel column chro-
matography (hexane/EtOAcꢂ1/0→9/1) afforded chloroformamide (Z)-2
(282 mg, 91%) as a colorless oil. Rf 0.46 (silica gel, hexane/EtOAcꢂ8/2).
1H-NMR* (CDCl3, 400 MHz) d: 8.14 (1H, br d, Jꢂ7.1 Hz), 7.54 (1H, dd,
J1ꢂ7.8 Hz, J2ꢂ10.7 Hz), 7.41 (1H, br s), 7.36—7.23 (7H, m), 5.45—5.40
(1H, m), 4.49 (2H, s), 3.98—3.94 (2H, m), 3.67—3.56 (2H, m), 3.29—3.25
(2H, m), 3.02—2.97 (2H, m), 2.05—1.99 (4H, m), 1.67 (11H, s), 1.01 (3H,
t, Jꢂ7.4 Hz). 13C-NMR* (CDCl3, 125 MHz) d: 149.7, 149.2, 148.9, 144.7,
144.5, 138.4, 138.4, 135.6, 130.2, 130.1, 128.4, 127.9, 127.70, 127.66,
124.76, 124.68, 123.4, 122.8, 120.9, 120.8, 118.8, 118.6, 116.8, 116.5,
115.54, 115.45, 83.8, 83.7, 72.4, 66.2, 66.1, 51.8, 51.2, 50.3, 50.2, 29.3,
28.29, 28.26, 27.8, 27.7, 27.2, 26.3, 24.6, 23.3, 12.5. IR (NaCl) cmꢁ1: 2968,
1734, 1454, 1376, 1256, 1158, 1088. LR-MS (FAB) m/zꢂ538 (Mꢀ). Anal.
Calcd for C31H39ClN2O4: C, 69.06; H, 7.29; N, 5.20. Found: C, 69.06; H,
7.35; N, 5.19 (* ca. 1 : 1 mixture of rotamers).
Indole 19 A solution of methyl ester 18 (144 mg, 0.325 mmol) in
CH3CN (4.0 ml) was irradiated microwave for 4 h at 200 °C, using a
maximum irradiation power of 150 W. The reaction mixture was con-
centrated in vacuo, and purification by silica gel column chromatography
(hexane/EtOAcꢂ1/0→6/4) afforded indole 19 (110 mg, 99%) as a colorless
oil. Rf 0.53 (silica gel, hexane/EtOAcꢂ3/7). 1H-NMR (CDCl3, 400 MHz) d:
8.19 (1H, br s), 7.68 (1H, d, Jꢂ7.8 Hz), 7.35 (1H, d, Jꢂ7.8 Hz), 7.18 (1H,
dd, J1ꢂJ2ꢂ7.8 Hz), 7.11 (1H, dd, J1ꢂJ2ꢂ7.8 Hz), 7.06 (1H, s), 3.67—3.63
(5H, m), 3.42—3.36 (1H, m), 3.22—3.17 (1H, m), 3.03 (2H, t, Jꢂ7.7 Hz),
2.96 (1H, d, Jꢂ16.1 Hz), 2.35 (1H, d, Jꢂ16.1 Hz), 1.99—1.60 (6H, m), 0.88
(3H, t, Jꢂ7.7 Hz). 13C-NMR (CDCl3, 125 MHz) d: 174.0, 172.7, 136.5,
127.7, 122.3, 122.1, 119.4, 119.1, 113.6, 111.3, 51.6, 49.1, 49.0, 43.6, 42.2,
31.7, 29.4, 23.1, 20.1, 8.8. IR (NaCl) cmꢁ1: 3268, 2946, 1736, 1615, 1492,
1457, 1435, 1355, 1198, 742. LR-MS (FAB) m/zꢂ343 (MꢀHꢀ). [a]D ꢁ1.9
(cꢂ1.0, CHCl3). Anal. Calcd for C20H26N2O3: C, 70.15; H, 7.65; N, 8.18.
Found: C, 69.92; H, 7.83; N, 7.88.
(ꢀ)-Epieburnamonine (20)
A solution of indole 19 (110 mg,
0.321 mmol) and POCl3 (0.120 ml, 1.28 mmol) in anhydrous CH3CN
(4.0 ml) was irradiated microwave for 3.5 h at 120 °C, using a maximum ir-
radiation power of 150 W. Then the reaction mixture was added dropwise
into a solution of NaBH4 (248 mg, 6.40 mmol) in MeOH (16 ml) at 0 °C.
After stirring for 25 min, water was added, and the mixture was extracted
Piperidone 1 A suspension of [Pd(h3-C3H5)Cl]2 (3.63 mg, 9.72 mmol),
t-BuOK (90% purity, 3.59 mg, 28.8 mmol), phosphoramidite L7 (39.8 mg,